Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia

Background β-thalassemia major is a hereditary disorder of hemoglobin (Hb) that results in defective Hb synthesis, leading to severe chronic anemia. The mainstay of its treatment is lifelong regular packed red cell transfusions associated with iron-chelating therapy. Globally, there is a gap between...

Descripción completa

Detalles Bibliográficos
Autores principales: Albagshi, Muneer H, Saad, Mona, Aljassem, Abdulmohsin M, Bushehab, Abdulaziz A, Ahmed, Noura H, Alabbad, Mahmoud M, Omer, Nawal, Alhamad, Osama A, Sultan, Tarig A, Bahgat, Samy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475924/
https://www.ncbi.nlm.nih.gov/pubmed/34603865
http://dx.doi.org/10.7759/cureus.17470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475924/
https://www.ncbi.nlm.nih.gov/pubmed/34603865
http://dx.doi.org/10.7759/cureus.17470

Ejemplares similares